A Agilent Technologies Inc.

Agilent Announces CrossLab Group Leadership Transition

Agilent Technologies Inc. (NYSE: A) today announced that Mark Doak, Agilent senior vice president and president of the Agilent CrossLab Group, has decided to retire on May 1, 2020. The company has named Padraig McDonnell, currently vice president and general manager, Chemistries and Supplies Division, to succeed him. Doak will continue as an active member of the executive staff until his retirement date, working with McDonnell to ensure a smooth transition.

Mark Doak has had a successful 42-year career in the analytical and scientific-instrument industry. He started his career with Beckman Instruments and later joined Hewlett-Packard (Agilent’s predecessor) in 1982. During his tenure with Agilent, he has held various senior-management positions across marketing, quality and services. Doak has led the Agilent CrossLab Group since 2014.

“Mark has been a key contributor to Agilent’s success for many years,” said Mike McMullen, Agilent president and CEO. “His leadership, knowledge and drive have helped make Agilent the industry leader it is today. I personally want to thank Mark for all that he has done to help lead our company and wish him all the best in his retirement.

“I’m also extremely pleased that Padraig McDonnell has accepted the role of leading our CrossLab Group upon Mark’s retirement. His history as a key member of Mark’s team, combined with his broad-based experience, track record of results and outstanding leadership skills, make Padraig the ideal person to take on this assignment. I have the utmost confidence he will continue to produce the same high level of success that Mark has achieved.”

McDonnell has been with Agilent for 22 years and has served in a variety of key sales and business-unit leadership positions. Prior to his current role leading the Chemistries and Supplies Division for the past three years, McDonnell was the vice president and general manager of Agilent’s Life Science and Applied Markets Group for Europe, the Middle East and India.

“While I was conflicted about retiring, Agilent and the Agilent CrossLab Group are in a solid position to continue their positive growth trajectories and the timing was right from an organizational perspective,” Doak said. “I look forward to working closely with Padraig in the coming months to help ensure a seamless transition.”

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, subscribe to the Agilent .

Follow Agilent on , , and .

EN
23/01/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Agilent Technologies, Inc.: Update to credit analysis

Our credit view of this issuer reflects its low financial leverage, against its high proportion of revenue from costly equipment sales, which has exposure to cyclical demand fluctuations

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 December 2025 in which we reassessed the appropriateness of the ratings in th...

Agilent Technologies Inc: 1 director

A director at Agilent Technologies Inc sold 2,600 shares at 149.812USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

6550-6569 S&P 500 Support Holding For Now After 5.5-months, the S&P 500 (SPX) has now failed to break and stay below the its 20-day MA. However, 6569 has been our level that needs to break in order for us to have confidence that a pullback has begun; SPX made a low of 6551 on Friday (less than 20 points or 0.3% from our 6569 level), meaning it was not a decisive breakdown (in time or price). As a result, our near-term bullish outlook since our 4/22/25 Compass remains intact, and it will stay t...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch